LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 8.12
(0.25%)
CNY 8.12
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 65.71 Million | 72.36 Million | 11.85 Million | 62.88 Million | 47.82 Million | 36.66 Million |
| Net Income | 68.12 Million | 105.92 Million | 93.51 Million | 111.67 Million | 74.66 Million | 74.27 Million |
| Depreciation & Amortization | 52.48 Million | 49.54 Million | 48.55 Million | 38.69 Million | 53.1 Million | 34.19 Million |
| Deferred income taxes | 222.26 Thousand | 966.61 Thousand | 171.88 Thousand | 2.31 Million | -40.69 Million | 430.57 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -82.29 Million | -112.2 Million | -116.97 Million | -32.98 Million | -86.91 Million | -60.48 Million |
| Other non-cash items | 27.4 Million | 29.1 Million | -13.24 Million | -54.48 Million | 6.97 Million | -11.32 Million |
| Investing Cash Flow | -34.15 Million | -42.84 Million | 42.64 Million | -61.88 Million | -58.03 Million | -292.13 Million |
| Investments in PPE | -22.47 Million | -41.5 Million | -32.8 Million | -122.57 Million | -93.15 Million | -261.11 Million |
| Acquisitions | -15.45 Million | 3.9 Million | 74.1 Million | 215.71 Million | -9.74 Million | 261.29 Million |
| Investment purchases | -6 Million | -2.13 Million | -3.93 Million | -176.93 Million | 95.06 Million | -45.4 Million |
| Sales/Maturities of investments | 8 Million | -3.9 Million | 38.08 Million | 144.49 Million | 42.94 Million | 14.2 Million |
| Other Investing Activities | 1.77 Million | 788.18 Thousand | -32.8 Million | -122.57 Million | -93.15 Million | -261.11 Million |
| Financing Cash Flow | -25 Million | -15.45 Million | -93.4 Million | -23.54 Million | -20.6 Million | 6.66 Million |
| Debt repayment | -21.45 Million | -14.21 Million | -35.27 Million | -14.53 Million | -17.3 Million | - |
| Dividends payments | -25.53 Million | -5.1 Million | -61.27 Million | -30.63 Million | -6.63 Million | -6.63 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.26 Million | 3.86 Million | 3.3 Million | 22.91 Million | 3.34 Million | 13.3 Million |
| Accounts receivables | 59.5 Million | -210.09 Million | -66.84 Million | -48.9 Million | -84.7 Million | -16.97 Million |
| Accounts payables | -134.73 Million | 188.62 Million | -49.49 Million | -17.81 Million | 83.54 Million | 1.21 Million |
| Inventory | -7.29 Million | -91.7 Million | -804.89 Thousand | 28.93 Million | -45.07 Million | -45.14 Million |
| Other working capital | 222.26 Thousand | 966.61 Thousand | 171.88 Thousand | 4.78 Million | -40.69 Million | -15.33 Million |
| Cash at beginning of period | 389.08 Million | 372.91 Million | 412.03 Million | 434.65 Million | 465.54 Million | 714.33 Million |
| Cash at end of period | 396.31 Million | 387.68 Million | 372.91 Million | 412.03 Million | 434.65 Million | 465.54 Million |
| Capital Expenditure | -22.47 Million | -41.5 Million | -32.8 Million | -122.57 Million | -93.15 Million | -261.11 Million |
| Effect of forex changes on cash | 674.47 Thousand | 699.78 Thousand | -207.57 Thousand | -79.58 Thousand | -78.65 Thousand | 12.96 Thousand |
| Net cash flow / Change in cash | 7.23 Million | 14.76 Million | -39.11 Million | -22.62 Million | -30.89 Million | -248.79 Million |
| Free Cash Flow | 43.24 Million | 30.86 Million | -20.95 Million | -59.68 Million | -45.32 Million | -224.45 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 17.7 Million | 18.38 Million | 68.12 Million | 8.07 Million | 2.06 Million |
| Depreciation & Amortization | - | 15.56 Million | 15.56 Million | 52.48 Million | 14.99 Million | -25.81 Million |
| Deferred income taxes | - | - | - | 222.26 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -31.03 Million | - | -82.29 Million | 66.84 Million | 161.89 Million |
| Other non-cash items | - | 7.16 Million | -34.46 Million | 27.4 Million | 28.77 Million | -139.12 Million |
| Investing Cash Flow | -1.23 Million | -5.45 Million | -2.09 Million | -34.15 Million | -26.95 Million | -3.39 Million |
| Investments in PPE | -1.23 Million | -5.46 Million | -2.09 Million | -22.47 Million | -13.26 Million | -3.39 Million |
| Acquisitions | - | 11.5 Thousand | - | -15.45 Million | -14.95 Million | - |
| Investment purchases | - | - | - | -6 Million | 14.95 Million | - |
| Sales/Maturities of investments | - | - | - | 8 Million | -16.35 Thousand | - |
| Other Investing Activities | - | 11.5 Thousand | - | 1.77 Million | -13.68 Million | - |
| Financing Cash Flow | -101.48 Thousand | -15.47 Million | -13.88 Million | -25 Million | -1.46 Million | -25.53 Million |
| Debt repayment | - | -486.66 Thousand | -13.88 Million | -21.45 Million | -8.05 Million | - |
| Dividends payments | -151.48 Thousand | -15.95 Million | - | -25.53 Million | -1.64 Million | - |
| Common Stock Repurchased | - | - | - | - | -500 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 50 Thousand | -15.95 Million | - | -1.26 Million | -1.76 Million | -25.53 Million |
| Accounts receivables | - | 16.72 Million | - | 59.5 Million | 59.5 Million | 115.7 Million |
| Accounts payables | - | - | - | -134.73 Million | - | - |
| Inventory | - | -47.75 Million | - | -7.29 Million | -7.29 Million | 46.18 Million |
| Other working capital | - | - | - | 222.26 Thousand | 14.63 Million | - |
| Cash at beginning of period | 362.36 Million | 365.33 Million | 396.31 Million | 389.08 Million | 305.73 Million | 310.11 Million |
| Cash at end of period | 351.62 Million | 362.36 Million | 364.26 Million | 396.31 Million | 396.31 Million | 305.73 Million |
| Capital Expenditure | -1.23 Million | -5.46 Million | -2.09 Million | -22.47 Million | -13.26 Million | -3.39 Million |
| Effect of forex changes on cash | - | - | -0.03 | 674.47 Thousand | 320.12 Thousand | 25.53 Million |
| Net cash flow / Change in cash | -10.74 Million | -2.96 Million | -32.05 Million | 7.23 Million | 90.58 Million | -4.38 Million |
| Free Cash Flow | -1.23 Million | 3.84 Million | -18.16 Million | 43.24 Million | 105.42 Million | -4.38 Million |
TUD
ASURB
000900
PROX
SEAL-PA
HTFC